Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
DXG31Q
|
||||
| Drug Name |
2-(cyclohexylmethyl)-4-morpholino-4-oxo-N-(1-(4-(trifluoromethoxy)phenylamino)propan-2-yl)butanamide
|
||||
| Synonyms |
CHEMBL492137
|
||||
| Indication | Discovery agent | Investigative | [1587926] | ||
| Formula |
C25H36F3N3O4
|
||||
| Canonical SMILES |
CC(CNc1ccc(OC(F)(F)F)cc1)NC(=O)C(CC2CCCCC2)CC(=O)N3CCOCC3
|
||||
| InChI |
InChI=1S/C25H36F3N3O4/c1-18(17-29-21-7-9-22(10-8-21)35-25(26,27)28)30-24(33)20(15-19-5-3-2-4-6-19)16-23(32)31-11-13-34-14-12-31/h7-10,18-20,29H,2-6,11-17H2,1H3,(H,30,33)
|
||||
| InChIKey |
LMIDTIHLIAUTKA-UHFFFAOYSA-N
|
||||
| Target and Pathway | |||||
| Target(s) | Cathepsin K | Target Info | [1587926] | ||
| Cathepsin L | Target Info | [1587926] | |||
| Reactome | Collagen degradation | ||||
| Degradation of the extracellular matrix | |||||
| Activation of Matrix Metalloproteinases | |||||
| Trafficking and processing of endosomal TLR | |||||
| MHC class II antigen presentationR-HSA-1236977:Endosomal/Vacuolar pathway | |||||
| Assembly of collagen fibrils and other multimeric structures | |||||
| MHC class II antigen presentation | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.